Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
20,707
archived clinical trials in
Gastrointestinal

Phase 1/2a Two-Arm Dose-Escalation Study of BAX69 in Subjects With Malignant Ascites of Ovarian Cancer
A Phase 1/2a, Open-Label, Parallel, Two-Arm Dose-Escalation Study to Assess the Safety, Tolerability, Efficacy, Pharmacokinetics, and Pharmacodynamics of BAX69 in Subjects With Refractory Ovarian Cancer With Malignant Ascites
Status: Enrolling
Updated:  10/19/2017
Augusta University
mi
from
Augusta, GA
Phase 1/2a Two-Arm Dose-Escalation Study of BAX69 in Subjects With Malignant Ascites of Ovarian Cancer
A Phase 1/2a, Open-Label, Parallel, Two-Arm Dose-Escalation Study to Assess the Safety, Tolerability, Efficacy, Pharmacokinetics, and Pharmacodynamics of BAX69 in Subjects With Refractory Ovarian Cancer With Malignant Ascites
Status: Enrolling
Updated: 10/19/2017
Augusta University
mi
from
Augusta, GA
Click here to add this to my saved trials
Phase 1/2a Two-Arm Dose-Escalation Study of BAX69 in Subjects With Malignant Ascites of Ovarian Cancer
A Phase 1/2a, Open-Label, Parallel, Two-Arm Dose-Escalation Study to Assess the Safety, Tolerability, Efficacy, Pharmacokinetics, and Pharmacodynamics of BAX69 in Subjects With Refractory Ovarian Cancer With Malignant Ascites
Status: Enrolling
Updated:  10/19/2017
Women's Health Specialists
mi
from
Silver Spring, MD
Phase 1/2a Two-Arm Dose-Escalation Study of BAX69 in Subjects With Malignant Ascites of Ovarian Cancer
A Phase 1/2a, Open-Label, Parallel, Two-Arm Dose-Escalation Study to Assess the Safety, Tolerability, Efficacy, Pharmacokinetics, and Pharmacodynamics of BAX69 in Subjects With Refractory Ovarian Cancer With Malignant Ascites
Status: Enrolling
Updated: 10/19/2017
Women's Health Specialists
mi
from
Silver Spring, MD
Click here to add this to my saved trials
Phase 1/2a Two-Arm Dose-Escalation Study of BAX69 in Subjects With Malignant Ascites of Ovarian Cancer
A Phase 1/2a, Open-Label, Parallel, Two-Arm Dose-Escalation Study to Assess the Safety, Tolerability, Efficacy, Pharmacokinetics, and Pharmacodynamics of BAX69 in Subjects With Refractory Ovarian Cancer With Malignant Ascites
Status: Enrolling
Updated:  10/19/2017
Stephenson Cancer Center at University of Oklahoma
mi
from
Oklahoma City, OK
Phase 1/2a Two-Arm Dose-Escalation Study of BAX69 in Subjects With Malignant Ascites of Ovarian Cancer
A Phase 1/2a, Open-Label, Parallel, Two-Arm Dose-Escalation Study to Assess the Safety, Tolerability, Efficacy, Pharmacokinetics, and Pharmacodynamics of BAX69 in Subjects With Refractory Ovarian Cancer With Malignant Ascites
Status: Enrolling
Updated: 10/19/2017
Stephenson Cancer Center at University of Oklahoma
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Phase 1/2a Two-Arm Dose-Escalation Study of BAX69 in Subjects With Malignant Ascites of Ovarian Cancer
A Phase 1/2a, Open-Label, Parallel, Two-Arm Dose-Escalation Study to Assess the Safety, Tolerability, Efficacy, Pharmacokinetics, and Pharmacodynamics of BAX69 in Subjects With Refractory Ovarian Cancer With Malignant Ascites
Status: Enrolling
Updated:  10/19/2017
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
Phase 1/2a Two-Arm Dose-Escalation Study of BAX69 in Subjects With Malignant Ascites of Ovarian Cancer
A Phase 1/2a, Open-Label, Parallel, Two-Arm Dose-Escalation Study to Assess the Safety, Tolerability, Efficacy, Pharmacokinetics, and Pharmacodynamics of BAX69 in Subjects With Refractory Ovarian Cancer With Malignant Ascites
Status: Enrolling
Updated: 10/19/2017
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
Phase 1/2a Two-Arm Dose-Escalation Study of BAX69 in Subjects With Malignant Ascites of Ovarian Cancer
A Phase 1/2a, Open-Label, Parallel, Two-Arm Dose-Escalation Study to Assess the Safety, Tolerability, Efficacy, Pharmacokinetics, and Pharmacodynamics of BAX69 in Subjects With Refractory Ovarian Cancer With Malignant Ascites
Status: Enrolling
Updated:  10/19/2017
Montefiore Medical Center
mi
from
The Bronx, NY
Phase 1/2a Two-Arm Dose-Escalation Study of BAX69 in Subjects With Malignant Ascites of Ovarian Cancer
A Phase 1/2a, Open-Label, Parallel, Two-Arm Dose-Escalation Study to Assess the Safety, Tolerability, Efficacy, Pharmacokinetics, and Pharmacodynamics of BAX69 in Subjects With Refractory Ovarian Cancer With Malignant Ascites
Status: Enrolling
Updated: 10/19/2017
Montefiore Medical Center
mi
from
The Bronx, NY
Click here to add this to my saved trials
Recombinant Leptin Therapy for Treatment of Nonalcoholic Steatohepatitis (NASH)
Nonalcoholic Steatohepatitis: is Leptin an Etiological Factor (Phase 2).
Status: Enrolling
Updated:  10/19/2017
University of Michigan
mi
from
Ann Arbor, MI
Recombinant Leptin Therapy for Treatment of Nonalcoholic Steatohepatitis (NASH)
Nonalcoholic Steatohepatitis: is Leptin an Etiological Factor (Phase 2).
Status: Enrolling
Updated: 10/19/2017
University of Michigan
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
An International Double Cohort Study to Compare Laparoscopic Ventral Rectopexy With Laparoscopic Resection Rectopexy
Laparoscopic Rectal Prolapse Surgery Study. An International, Double Cohort Study to Determine the Optimal Treatment for Rectal Prolapse.
Status: Enrolling
Updated:  10/20/2017
Florida Hospital
mi
from
Orlando, FL
An International Double Cohort Study to Compare Laparoscopic Ventral Rectopexy With Laparoscopic Resection Rectopexy
Laparoscopic Rectal Prolapse Surgery Study. An International, Double Cohort Study to Determine the Optimal Treatment for Rectal Prolapse.
Status: Enrolling
Updated: 10/20/2017
Florida Hospital
mi
from
Orlando, FL
Click here to add this to my saved trials
An International Double Cohort Study to Compare Laparoscopic Ventral Rectopexy With Laparoscopic Resection Rectopexy
Laparoscopic Rectal Prolapse Surgery Study. An International, Double Cohort Study to Determine the Optimal Treatment for Rectal Prolapse.
Status: Enrolling
Updated:  10/20/2017
Tampa General Hospital
mi
from
Tampa, FL
An International Double Cohort Study to Compare Laparoscopic Ventral Rectopexy With Laparoscopic Resection Rectopexy
Laparoscopic Rectal Prolapse Surgery Study. An International, Double Cohort Study to Determine the Optimal Treatment for Rectal Prolapse.
Status: Enrolling
Updated: 10/20/2017
Tampa General Hospital
mi
from
Tampa, FL
Click here to add this to my saved trials
An International Double Cohort Study to Compare Laparoscopic Ventral Rectopexy With Laparoscopic Resection Rectopexy
Laparoscopic Rectal Prolapse Surgery Study. An International, Double Cohort Study to Determine the Optimal Treatment for Rectal Prolapse.
Status: Enrolling
Updated:  10/20/2017
Cleveland Clinic Floria
mi
from
Weston, FL
An International Double Cohort Study to Compare Laparoscopic Ventral Rectopexy With Laparoscopic Resection Rectopexy
Laparoscopic Rectal Prolapse Surgery Study. An International, Double Cohort Study to Determine the Optimal Treatment for Rectal Prolapse.
Status: Enrolling
Updated: 10/20/2017
Cleveland Clinic Floria
mi
from
Weston, FL
Click here to add this to my saved trials
An International Double Cohort Study to Compare Laparoscopic Ventral Rectopexy With Laparoscopic Resection Rectopexy
Laparoscopic Rectal Prolapse Surgery Study. An International, Double Cohort Study to Determine the Optimal Treatment for Rectal Prolapse.
Status: Enrolling
Updated:  10/20/2017
Oschner Clinic North Shore
mi
from
New Orleans, LA
An International Double Cohort Study to Compare Laparoscopic Ventral Rectopexy With Laparoscopic Resection Rectopexy
Laparoscopic Rectal Prolapse Surgery Study. An International, Double Cohort Study to Determine the Optimal Treatment for Rectal Prolapse.
Status: Enrolling
Updated: 10/20/2017
Oschner Clinic North Shore
mi
from
New Orleans, LA
Click here to add this to my saved trials
An International Double Cohort Study to Compare Laparoscopic Ventral Rectopexy With Laparoscopic Resection Rectopexy
Laparoscopic Rectal Prolapse Surgery Study. An International, Double Cohort Study to Determine the Optimal Treatment for Rectal Prolapse.
Status: Enrolling
Updated:  10/20/2017
John Hopkins
mi
from
Baltimore, MD
An International Double Cohort Study to Compare Laparoscopic Ventral Rectopexy With Laparoscopic Resection Rectopexy
Laparoscopic Rectal Prolapse Surgery Study. An International, Double Cohort Study to Determine the Optimal Treatment for Rectal Prolapse.
Status: Enrolling
Updated: 10/20/2017
John Hopkins
mi
from
Baltimore, MD
Click here to add this to my saved trials
An International Double Cohort Study to Compare Laparoscopic Ventral Rectopexy With Laparoscopic Resection Rectopexy
Laparoscopic Rectal Prolapse Surgery Study. An International, Double Cohort Study to Determine the Optimal Treatment for Rectal Prolapse.
Status: Enrolling
Updated:  10/20/2017
Lahey Medical Center
mi
from
Burlington, MA
An International Double Cohort Study to Compare Laparoscopic Ventral Rectopexy With Laparoscopic Resection Rectopexy
Laparoscopic Rectal Prolapse Surgery Study. An International, Double Cohort Study to Determine the Optimal Treatment for Rectal Prolapse.
Status: Enrolling
Updated: 10/20/2017
Lahey Medical Center
mi
from
Burlington, MA
Click here to add this to my saved trials
Randomized Controlled Trial of Endoscopic Dilation: Triamcinolone Injection
Randomized Controlled Trial of Endoscopic Dilation With or Without Triamcinolone Injection in Patients With Non-malignant Radiation or Anastomotic Esophageal Strictures
Status: Enrolling
Updated:  10/20/2017
H. Lee Moffitt Cancer Center & Research Institute
mi
from
Tampa, FL
Randomized Controlled Trial of Endoscopic Dilation: Triamcinolone Injection
Randomized Controlled Trial of Endoscopic Dilation With or Without Triamcinolone Injection in Patients With Non-malignant Radiation or Anastomotic Esophageal Strictures
Status: Enrolling
Updated: 10/20/2017
H. Lee Moffitt Cancer Center & Research Institute
mi
from
Tampa, FL
Click here to add this to my saved trials
Treatment of Hepatic Encephalopathy With Flumazenil and Change in Cortical GABA Levels in MRS
Treatment of Hepatic Encephalopathy With Benzodiazepine Antagonist (Flumazenil) and Change in Cortical GABA Levels in Localized 1H-MR Spectroscopy
Status: Enrolling
Updated:  10/20/2017
Yale Psychological Medicine Research Center
mi
from
New Haven, CT
Treatment of Hepatic Encephalopathy With Flumazenil and Change in Cortical GABA Levels in MRS
Treatment of Hepatic Encephalopathy With Benzodiazepine Antagonist (Flumazenil) and Change in Cortical GABA Levels in Localized 1H-MR Spectroscopy
Status: Enrolling
Updated: 10/20/2017
Yale Psychological Medicine Research Center
mi
from
New Haven, CT
Click here to add this to my saved trials
The Efficacy Side Effects and the Tolerance of Polyethylene Glycol 3350 as a Bowel Prep in Children
The Efficacy Side Effects and the Tolerance of Polyethylene Glycol 3350 as a Bowel Prep in Children
Status: Enrolling
Updated:  10/20/2017
Cleveland Clinic Childrens Hospital
mi
from
Cleveland, OH
The Efficacy Side Effects and the Tolerance of Polyethylene Glycol 3350 as a Bowel Prep in Children
The Efficacy Side Effects and the Tolerance of Polyethylene Glycol 3350 as a Bowel Prep in Children
Status: Enrolling
Updated: 10/20/2017
Cleveland Clinic Childrens Hospital
mi
from
Cleveland, OH
Click here to add this to my saved trials
Characteristics of Eosinophilic Gastritis, Enteritis, and Colitis in a Multi-Site Cohort
Demographics, Clinical Characteristics, and Pathology of Eosinophilic Gastritis, Enteritis, and Colitis in a Multi-Site Cohort
Status: Enrolling
Updated:  10/20/2017
University of Arkansas for Medical Science
mi
from
Little Rock, AR
Characteristics of Eosinophilic Gastritis, Enteritis, and Colitis in a Multi-Site Cohort
Demographics, Clinical Characteristics, and Pathology of Eosinophilic Gastritis, Enteritis, and Colitis in a Multi-Site Cohort
Status: Enrolling
Updated: 10/20/2017
University of Arkansas for Medical Science
mi
from
Little Rock, AR
Click here to add this to my saved trials
Characteristics of Eosinophilic Gastritis, Enteritis, and Colitis in a Multi-Site Cohort
Demographics, Clinical Characteristics, and Pathology of Eosinophilic Gastritis, Enteritis, and Colitis in a Multi-Site Cohort
Status: Enrolling
Updated:  10/20/2017
Childrens Hospital Colorado
mi
from
Denver, CO
Characteristics of Eosinophilic Gastritis, Enteritis, and Colitis in a Multi-Site Cohort
Demographics, Clinical Characteristics, and Pathology of Eosinophilic Gastritis, Enteritis, and Colitis in a Multi-Site Cohort
Status: Enrolling
Updated: 10/20/2017
Childrens Hospital Colorado
mi
from
Denver, CO
Click here to add this to my saved trials
Characteristics of Eosinophilic Gastritis, Enteritis, and Colitis in a Multi-Site Cohort
Demographics, Clinical Characteristics, and Pathology of Eosinophilic Gastritis, Enteritis, and Colitis in a Multi-Site Cohort
Status: Enrolling
Updated:  10/20/2017
Northwestern University
mi
from
Chicago, IL
Characteristics of Eosinophilic Gastritis, Enteritis, and Colitis in a Multi-Site Cohort
Demographics, Clinical Characteristics, and Pathology of Eosinophilic Gastritis, Enteritis, and Colitis in a Multi-Site Cohort
Status: Enrolling
Updated: 10/20/2017
Northwestern University
mi
from
Chicago, IL
Click here to add this to my saved trials
Characteristics of Eosinophilic Gastritis, Enteritis, and Colitis in a Multi-Site Cohort
Demographics, Clinical Characteristics, and Pathology of Eosinophilic Gastritis, Enteritis, and Colitis in a Multi-Site Cohort
Status: Enrolling
Updated:  10/20/2017
Ann & Robert H. Lurie Children's Hospital of Chicago
mi
from
Chicago, IL
Characteristics of Eosinophilic Gastritis, Enteritis, and Colitis in a Multi-Site Cohort
Demographics, Clinical Characteristics, and Pathology of Eosinophilic Gastritis, Enteritis, and Colitis in a Multi-Site Cohort
Status: Enrolling
Updated: 10/20/2017
Ann & Robert H. Lurie Children's Hospital of Chicago
mi
from
Chicago, IL
Click here to add this to my saved trials
Characteristics of Eosinophilic Gastritis, Enteritis, and Colitis in a Multi-Site Cohort
Demographics, Clinical Characteristics, and Pathology of Eosinophilic Gastritis, Enteritis, and Colitis in a Multi-Site Cohort
Status: Enrolling
Updated:  10/20/2017
Tufts University School of Medicine
mi
from
Boston, MA
Characteristics of Eosinophilic Gastritis, Enteritis, and Colitis in a Multi-Site Cohort
Demographics, Clinical Characteristics, and Pathology of Eosinophilic Gastritis, Enteritis, and Colitis in a Multi-Site Cohort
Status: Enrolling
Updated: 10/20/2017
Tufts University School of Medicine
mi
from
Boston, MA
Click here to add this to my saved trials
Characteristics of Eosinophilic Gastritis, Enteritis, and Colitis in a Multi-Site Cohort
Demographics, Clinical Characteristics, and Pathology of Eosinophilic Gastritis, Enteritis, and Colitis in a Multi-Site Cohort
Status: Enrolling
Updated:  10/20/2017
University of North Carolina at Chapel Hill
mi
from
Chapel Hill, NC
Characteristics of Eosinophilic Gastritis, Enteritis, and Colitis in a Multi-Site Cohort
Demographics, Clinical Characteristics, and Pathology of Eosinophilic Gastritis, Enteritis, and Colitis in a Multi-Site Cohort
Status: Enrolling
Updated: 10/20/2017
University of North Carolina at Chapel Hill
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Characteristics of Eosinophilic Gastritis, Enteritis, and Colitis in a Multi-Site Cohort
Demographics, Clinical Characteristics, and Pathology of Eosinophilic Gastritis, Enteritis, and Colitis in a Multi-Site Cohort
Status: Enrolling
Updated:  10/20/2017
Cincinnati Children's Hospital Medical Center
mi
from
Cincinnati, OH
Characteristics of Eosinophilic Gastritis, Enteritis, and Colitis in a Multi-Site Cohort
Demographics, Clinical Characteristics, and Pathology of Eosinophilic Gastritis, Enteritis, and Colitis in a Multi-Site Cohort
Status: Enrolling
Updated: 10/20/2017
Cincinnati Children's Hospital Medical Center
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Characteristics of Eosinophilic Gastritis, Enteritis, and Colitis in a Multi-Site Cohort
Demographics, Clinical Characteristics, and Pathology of Eosinophilic Gastritis, Enteritis, and Colitis in a Multi-Site Cohort
Status: Enrolling
Updated:  10/20/2017
Univ of Pennsylvania
mi
from
Philadelphia, PA
Characteristics of Eosinophilic Gastritis, Enteritis, and Colitis in a Multi-Site Cohort
Demographics, Clinical Characteristics, and Pathology of Eosinophilic Gastritis, Enteritis, and Colitis in a Multi-Site Cohort
Status: Enrolling
Updated: 10/20/2017
Univ of Pennsylvania
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Safety and Efficacy Study of Ursodeoxycholic Acid Therapy in Pediatric Primary Sclerosing Cholangitis
Ursodeoxycholic Acid Therapy in Pediatric Primary Sclerosing Cholangitis: A Pilot Withdrawal/Reinstitution Trial
Status: Enrolling
Updated:  10/24/2017
Phoenix Children's Hospital
mi
from
Phoenix, AZ
Safety and Efficacy Study of Ursodeoxycholic Acid Therapy in Pediatric Primary Sclerosing Cholangitis
Ursodeoxycholic Acid Therapy in Pediatric Primary Sclerosing Cholangitis: A Pilot Withdrawal/Reinstitution Trial
Status: Enrolling
Updated: 10/24/2017
Phoenix Children's Hospital
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Safety and Efficacy Study of Ursodeoxycholic Acid Therapy in Pediatric Primary Sclerosing Cholangitis
Ursodeoxycholic Acid Therapy in Pediatric Primary Sclerosing Cholangitis: A Pilot Withdrawal/Reinstitution Trial
Status: Enrolling
Updated:  10/24/2017
Childrens Hospital Los Angeles
mi
from
Los Angeles, CA
Safety and Efficacy Study of Ursodeoxycholic Acid Therapy in Pediatric Primary Sclerosing Cholangitis
Ursodeoxycholic Acid Therapy in Pediatric Primary Sclerosing Cholangitis: A Pilot Withdrawal/Reinstitution Trial
Status: Enrolling
Updated: 10/24/2017
Childrens Hospital Los Angeles
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Safety and Efficacy Study of Ursodeoxycholic Acid Therapy in Pediatric Primary Sclerosing Cholangitis
Ursodeoxycholic Acid Therapy in Pediatric Primary Sclerosing Cholangitis: A Pilot Withdrawal/Reinstitution Trial
Status: Enrolling
Updated:  10/24/2017
University of California at San Francisco
mi
from
San Francisco, CA
Safety and Efficacy Study of Ursodeoxycholic Acid Therapy in Pediatric Primary Sclerosing Cholangitis
Ursodeoxycholic Acid Therapy in Pediatric Primary Sclerosing Cholangitis: A Pilot Withdrawal/Reinstitution Trial
Status: Enrolling
Updated: 10/24/2017
University of California at San Francisco
mi
from
San Francisco, CA
Click here to add this to my saved trials
Safety and Efficacy Study of Ursodeoxycholic Acid Therapy in Pediatric Primary Sclerosing Cholangitis
Ursodeoxycholic Acid Therapy in Pediatric Primary Sclerosing Cholangitis: A Pilot Withdrawal/Reinstitution Trial
Status: Enrolling
Updated:  10/24/2017
Children's Hospital Colorado
mi
from
Aurora, CO
Safety and Efficacy Study of Ursodeoxycholic Acid Therapy in Pediatric Primary Sclerosing Cholangitis
Ursodeoxycholic Acid Therapy in Pediatric Primary Sclerosing Cholangitis: A Pilot Withdrawal/Reinstitution Trial
Status: Enrolling
Updated: 10/24/2017
Children's Hospital Colorado
mi
from
Aurora, CO
Click here to add this to my saved trials
Safety and Efficacy Study of Ursodeoxycholic Acid Therapy in Pediatric Primary Sclerosing Cholangitis
Ursodeoxycholic Acid Therapy in Pediatric Primary Sclerosing Cholangitis: A Pilot Withdrawal/Reinstitution Trial
Status: Enrolling
Updated:  10/24/2017
Children's Healthcare of Atlanta/Emory University School of Medicine
mi
from
Atlanta, GA
Safety and Efficacy Study of Ursodeoxycholic Acid Therapy in Pediatric Primary Sclerosing Cholangitis
Ursodeoxycholic Acid Therapy in Pediatric Primary Sclerosing Cholangitis: A Pilot Withdrawal/Reinstitution Trial
Status: Enrolling
Updated: 10/24/2017
Children's Healthcare of Atlanta/Emory University School of Medicine
mi
from
Atlanta, GA
Click here to add this to my saved trials
Safety and Efficacy Study of Ursodeoxycholic Acid Therapy in Pediatric Primary Sclerosing Cholangitis
Ursodeoxycholic Acid Therapy in Pediatric Primary Sclerosing Cholangitis: A Pilot Withdrawal/Reinstitution Trial
Status: Enrolling
Updated:  10/24/2017
Northwestern University
mi
from
Chicago, IL
Safety and Efficacy Study of Ursodeoxycholic Acid Therapy in Pediatric Primary Sclerosing Cholangitis
Ursodeoxycholic Acid Therapy in Pediatric Primary Sclerosing Cholangitis: A Pilot Withdrawal/Reinstitution Trial
Status: Enrolling
Updated: 10/24/2017
Northwestern University
mi
from
Chicago, IL
Click here to add this to my saved trials
Safety and Efficacy Study of Ursodeoxycholic Acid Therapy in Pediatric Primary Sclerosing Cholangitis
Ursodeoxycholic Acid Therapy in Pediatric Primary Sclerosing Cholangitis: A Pilot Withdrawal/Reinstitution Trial
Status: Enrolling
Updated:  10/24/2017
Children's Hospital of Philadelphia
mi
from
Philadelphia, PA
Safety and Efficacy Study of Ursodeoxycholic Acid Therapy in Pediatric Primary Sclerosing Cholangitis
Ursodeoxycholic Acid Therapy in Pediatric Primary Sclerosing Cholangitis: A Pilot Withdrawal/Reinstitution Trial
Status: Enrolling
Updated: 10/24/2017
Children's Hospital of Philadelphia
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Safety and Efficacy Study of Ursodeoxycholic Acid Therapy in Pediatric Primary Sclerosing Cholangitis
Ursodeoxycholic Acid Therapy in Pediatric Primary Sclerosing Cholangitis: A Pilot Withdrawal/Reinstitution Trial
Status: Enrolling
Updated:  10/24/2017
University of Pittsburgh
mi
from
Pittsburgh, PA
Safety and Efficacy Study of Ursodeoxycholic Acid Therapy in Pediatric Primary Sclerosing Cholangitis
Ursodeoxycholic Acid Therapy in Pediatric Primary Sclerosing Cholangitis: A Pilot Withdrawal/Reinstitution Trial
Status: Enrolling
Updated: 10/24/2017
University of Pittsburgh
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Safety and Efficacy Study of Ursodeoxycholic Acid Therapy in Pediatric Primary Sclerosing Cholangitis
Ursodeoxycholic Acid Therapy in Pediatric Primary Sclerosing Cholangitis: A Pilot Withdrawal/Reinstitution Trial
Status: Enrolling
Updated:  10/24/2017
University of Tennessee Health Science Center
mi
from
Memphis, TN
Safety and Efficacy Study of Ursodeoxycholic Acid Therapy in Pediatric Primary Sclerosing Cholangitis
Ursodeoxycholic Acid Therapy in Pediatric Primary Sclerosing Cholangitis: A Pilot Withdrawal/Reinstitution Trial
Status: Enrolling
Updated: 10/24/2017
University of Tennessee Health Science Center
mi
from
Memphis, TN
Click here to add this to my saved trials
Safety and Efficacy Study of Ursodeoxycholic Acid Therapy in Pediatric Primary Sclerosing Cholangitis
Ursodeoxycholic Acid Therapy in Pediatric Primary Sclerosing Cholangitis: A Pilot Withdrawal/Reinstitution Trial
Status: Enrolling
Updated:  10/24/2017
Mount Sinai School of Medicine
mi
from
New York, NY
Safety and Efficacy Study of Ursodeoxycholic Acid Therapy in Pediatric Primary Sclerosing Cholangitis
Ursodeoxycholic Acid Therapy in Pediatric Primary Sclerosing Cholangitis: A Pilot Withdrawal/Reinstitution Trial
Status: Enrolling
Updated: 10/24/2017
Mount Sinai School of Medicine
mi
from
New York, NY
Click here to add this to my saved trials
Safety and Efficacy Study of Ursodeoxycholic Acid Therapy in Pediatric Primary Sclerosing Cholangitis
Ursodeoxycholic Acid Therapy in Pediatric Primary Sclerosing Cholangitis: A Pilot Withdrawal/Reinstitution Trial
Status: Enrolling
Updated:  10/24/2017
Yale-New Haven Children's Hospital
mi
from
New Haven, CT
Safety and Efficacy Study of Ursodeoxycholic Acid Therapy in Pediatric Primary Sclerosing Cholangitis
Ursodeoxycholic Acid Therapy in Pediatric Primary Sclerosing Cholangitis: A Pilot Withdrawal/Reinstitution Trial
Status: Enrolling
Updated: 10/24/2017
Yale-New Haven Children's Hospital
mi
from
New Haven, CT
Click here to add this to my saved trials
Safety and Efficacy Study of Ursodeoxycholic Acid Therapy in Pediatric Primary Sclerosing Cholangitis
Ursodeoxycholic Acid Therapy in Pediatric Primary Sclerosing Cholangitis: A Pilot Withdrawal/Reinstitution Trial
Status: Enrolling
Updated:  10/24/2017
Texas Children's Hospital
mi
from
Houston, TX
Safety and Efficacy Study of Ursodeoxycholic Acid Therapy in Pediatric Primary Sclerosing Cholangitis
Ursodeoxycholic Acid Therapy in Pediatric Primary Sclerosing Cholangitis: A Pilot Withdrawal/Reinstitution Trial
Status: Enrolling
Updated: 10/24/2017
Texas Children's Hospital
mi
from
Houston, TX
Click here to add this to my saved trials
Interventions to Decrease the Impact of Post-OPerative Ileus After Liver Transplant or Resection Surgery
Interventions to Decrease the Impact of Post-Operative Ileus After Liver Transplant or Resection Surgery
Status: Enrolling
Updated:  10/24/2017
Nebraska Medical Center
mi
from
Omaha, NE
Interventions to Decrease the Impact of Post-OPerative Ileus After Liver Transplant or Resection Surgery
Interventions to Decrease the Impact of Post-Operative Ileus After Liver Transplant or Resection Surgery
Status: Enrolling
Updated: 10/24/2017
Nebraska Medical Center
mi
from
Omaha, NE
Click here to add this to my saved trials
Impact of Physical Activity on Left Ventricular Mass and Lipid Metabolism
Impact of Physical Activity on Left Ventricular Mass and Lipid Metabolism in Healthy Female Volunteers Training for a Marathon
Status: Enrolling
Updated:  10/24/2017
CTSI - University of California San Francisco
mi
from
San Francisco, CA
Impact of Physical Activity on Left Ventricular Mass and Lipid Metabolism
Impact of Physical Activity on Left Ventricular Mass and Lipid Metabolism in Healthy Female Volunteers Training for a Marathon
Status: Enrolling
Updated: 10/24/2017
CTSI - University of California San Francisco
mi
from
San Francisco, CA
Click here to add this to my saved trials
Main Study of Lofexidine and Methadone Pharmacodynamic Interaction in Methadone Maintained Patients
A Randomized, Double-Blind, Placebo-Controlled, Multiple Ascending Dose Study to Assess the Safety, Tolerability, and Electrocardiographic Effects of Lofexidine When Administered Orally to Methadone Maintained Adult Subjects
Status: Enrolling
Updated:  10/24/2017
Lifetree Clinical Research
mi
from
Salt Lake City, UT
Main Study of Lofexidine and Methadone Pharmacodynamic Interaction in Methadone Maintained Patients
A Randomized, Double-Blind, Placebo-Controlled, Multiple Ascending Dose Study to Assess the Safety, Tolerability, and Electrocardiographic Effects of Lofexidine When Administered Orally to Methadone Maintained Adult Subjects
Status: Enrolling
Updated: 10/24/2017
Lifetree Clinical Research
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
The Cirrhosis Outpatient Optimization, Readmission & Safety Study
COORS: The Cirrhosis Outpatient Optimization, Readmission & Safety Study
Status: Enrolling
Updated:  10/24/2017
UCLA Center for Inflammatory Bowel Diseases
mi
from
Los Angeles, CA
The Cirrhosis Outpatient Optimization, Readmission & Safety Study
COORS: The Cirrhosis Outpatient Optimization, Readmission & Safety Study
Status: Enrolling
Updated: 10/24/2017
UCLA Center for Inflammatory Bowel Diseases
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Patient-Centered Care and Asian Americans
A Patient-Centered Intervention to Increase Screening of Hepatitis B and C Among Asian Americans
Status: Enrolling
Updated:  10/24/2017
San Francisco General Hospital
mi
from
San Francisco, CA
Patient-Centered Care and Asian Americans
A Patient-Centered Intervention to Increase Screening of Hepatitis B and C Among Asian Americans
Status: Enrolling
Updated: 10/24/2017
San Francisco General Hospital
mi
from
San Francisco, CA
Click here to add this to my saved trials
Patient-Centered Care and Asian Americans
A Patient-Centered Intervention to Increase Screening of Hepatitis B and C Among Asian Americans
Status: Enrolling
Updated:  10/24/2017
UCSF
mi
from
San Francisco, CA
Patient-Centered Care and Asian Americans
A Patient-Centered Intervention to Increase Screening of Hepatitis B and C Among Asian Americans
Status: Enrolling
Updated: 10/24/2017
UCSF
mi
from
San Francisco, CA
Click here to add this to my saved trials
Study to Evaluate the Exposures of Lofexidine and Its Major Metabolites in Subjects Seeking Buprenorphine Dose Reduction
A Phase 1 Study to Evaluate the Relative Exposures of Lofexidine and Its Major Metabolites in Subjects Seeking Buprenorphine Dose Reduction
Status: Enrolling
Updated:  10/24/2017
Clinical Research Facility
mi
from
Overland Park, KA
Study to Evaluate the Exposures of Lofexidine and Its Major Metabolites in Subjects Seeking Buprenorphine Dose Reduction
A Phase 1 Study to Evaluate the Relative Exposures of Lofexidine and Its Major Metabolites in Subjects Seeking Buprenorphine Dose Reduction
Status: Enrolling
Updated: 10/24/2017
Clinical Research Facility
mi
from
Overland Park, KA
Click here to add this to my saved trials
The Effect of 16 Weeks of Hip Adduction and Abduction Resistance Exercise
The Effect of 16 Weeks of Hip Adduction and Abduction Resistance Exercise Training on Strength and Density of the Proximal Femur
Status: Enrolling
Updated:  10/25/2017
UCSF-Department of radiology-China Basin
mi
from
San Francisco, CA
The Effect of 16 Weeks of Hip Adduction and Abduction Resistance Exercise
The Effect of 16 Weeks of Hip Adduction and Abduction Resistance Exercise Training on Strength and Density of the Proximal Femur
Status: Enrolling
Updated: 10/25/2017
UCSF-Department of radiology-China Basin
mi
from
San Francisco, CA
Click here to add this to my saved trials
A Study in Ovarian, Non-Small Cell Lung, Prostate, Colorectal, Gastroesophageal Cancers, and Squamous Cell Carcinoma of the Head and Neck
A Phase 2 Indication Identification Study of LY2523355 in Patients With Ovarian, Non-Small Cell Lung, Prostate, Colorectal, Gastroesophageal Cancers, and Squamous Cell Carcinoma of the Head and Neck
Status: Enrolling
Updated:  10/28/2017
Clinical Research Facility
mi
from
Bethesda, MD
A Study in Ovarian, Non-Small Cell Lung, Prostate, Colorectal, Gastroesophageal Cancers, and Squamous Cell Carcinoma of the Head and Neck
A Phase 2 Indication Identification Study of LY2523355 in Patients With Ovarian, Non-Small Cell Lung, Prostate, Colorectal, Gastroesophageal Cancers, and Squamous Cell Carcinoma of the Head and Neck
Status: Enrolling
Updated: 10/28/2017
Clinical Research Facility
mi
from
Bethesda, MD
Click here to add this to my saved trials
A Study in Ovarian, Non-Small Cell Lung, Prostate, Colorectal, Gastroesophageal Cancers, and Squamous Cell Carcinoma of the Head and Neck
A Phase 2 Indication Identification Study of LY2523355 in Patients With Ovarian, Non-Small Cell Lung, Prostate, Colorectal, Gastroesophageal Cancers, and Squamous Cell Carcinoma of the Head and Neck
Status: Enrolling
Updated:  10/28/2017
Clinical Research Facility
mi
from
Jonesboro, AR
A Study in Ovarian, Non-Small Cell Lung, Prostate, Colorectal, Gastroesophageal Cancers, and Squamous Cell Carcinoma of the Head and Neck
A Phase 2 Indication Identification Study of LY2523355 in Patients With Ovarian, Non-Small Cell Lung, Prostate, Colorectal, Gastroesophageal Cancers, and Squamous Cell Carcinoma of the Head and Neck
Status: Enrolling
Updated: 10/28/2017
Clinical Research Facility
mi
from
Jonesboro, AR
Click here to add this to my saved trials
A Study in Ovarian, Non-Small Cell Lung, Prostate, Colorectal, Gastroesophageal Cancers, and Squamous Cell Carcinoma of the Head and Neck
A Phase 2 Indication Identification Study of LY2523355 in Patients With Ovarian, Non-Small Cell Lung, Prostate, Colorectal, Gastroesophageal Cancers, and Squamous Cell Carcinoma of the Head and Neck
Status: Enrolling
Updated:  10/28/2017
Clinical Research Facility
mi
from
Jacksonville, FL
A Study in Ovarian, Non-Small Cell Lung, Prostate, Colorectal, Gastroesophageal Cancers, and Squamous Cell Carcinoma of the Head and Neck
A Phase 2 Indication Identification Study of LY2523355 in Patients With Ovarian, Non-Small Cell Lung, Prostate, Colorectal, Gastroesophageal Cancers, and Squamous Cell Carcinoma of the Head and Neck
Status: Enrolling
Updated: 10/28/2017
Clinical Research Facility
mi
from
Jacksonville, FL
Click here to add this to my saved trials
A Study in Ovarian, Non-Small Cell Lung, Prostate, Colorectal, Gastroesophageal Cancers, and Squamous Cell Carcinoma of the Head and Neck
A Phase 2 Indication Identification Study of LY2523355 in Patients With Ovarian, Non-Small Cell Lung, Prostate, Colorectal, Gastroesophageal Cancers, and Squamous Cell Carcinoma of the Head and Neck
Status: Enrolling
Updated:  10/28/2017
Clinical Research Facility
mi
from
Macon, GA
A Study in Ovarian, Non-Small Cell Lung, Prostate, Colorectal, Gastroesophageal Cancers, and Squamous Cell Carcinoma of the Head and Neck
A Phase 2 Indication Identification Study of LY2523355 in Patients With Ovarian, Non-Small Cell Lung, Prostate, Colorectal, Gastroesophageal Cancers, and Squamous Cell Carcinoma of the Head and Neck
Status: Enrolling
Updated: 10/28/2017
Clinical Research Facility
mi
from
Macon, GA
Click here to add this to my saved trials
A Study in Ovarian, Non-Small Cell Lung, Prostate, Colorectal, Gastroesophageal Cancers, and Squamous Cell Carcinoma of the Head and Neck
A Phase 2 Indication Identification Study of LY2523355 in Patients With Ovarian, Non-Small Cell Lung, Prostate, Colorectal, Gastroesophageal Cancers, and Squamous Cell Carcinoma of the Head and Neck
Status: Enrolling
Updated:  10/28/2017
Clinical Research Facility
mi
from
Marietta, GA
A Study in Ovarian, Non-Small Cell Lung, Prostate, Colorectal, Gastroesophageal Cancers, and Squamous Cell Carcinoma of the Head and Neck
A Phase 2 Indication Identification Study of LY2523355 in Patients With Ovarian, Non-Small Cell Lung, Prostate, Colorectal, Gastroesophageal Cancers, and Squamous Cell Carcinoma of the Head and Neck
Status: Enrolling
Updated: 10/28/2017
Clinical Research Facility
mi
from
Marietta, GA
Click here to add this to my saved trials
A Study in Ovarian, Non-Small Cell Lung, Prostate, Colorectal, Gastroesophageal Cancers, and Squamous Cell Carcinoma of the Head and Neck
A Phase 2 Indication Identification Study of LY2523355 in Patients With Ovarian, Non-Small Cell Lung, Prostate, Colorectal, Gastroesophageal Cancers, and Squamous Cell Carcinoma of the Head and Neck
Status: Enrolling
Updated:  10/28/2017
Clinical Research Facility
mi
from
Valdosta, GA
A Study in Ovarian, Non-Small Cell Lung, Prostate, Colorectal, Gastroesophageal Cancers, and Squamous Cell Carcinoma of the Head and Neck
A Phase 2 Indication Identification Study of LY2523355 in Patients With Ovarian, Non-Small Cell Lung, Prostate, Colorectal, Gastroesophageal Cancers, and Squamous Cell Carcinoma of the Head and Neck
Status: Enrolling
Updated: 10/28/2017
Clinical Research Facility
mi
from
Valdosta, GA
Click here to add this to my saved trials
A Study in Ovarian, Non-Small Cell Lung, Prostate, Colorectal, Gastroesophageal Cancers, and Squamous Cell Carcinoma of the Head and Neck
A Phase 2 Indication Identification Study of LY2523355 in Patients With Ovarian, Non-Small Cell Lung, Prostate, Colorectal, Gastroesophageal Cancers, and Squamous Cell Carcinoma of the Head and Neck
Status: Enrolling
Updated:  10/28/2017
Clinical Research Facility
mi
from
Post Falls, ID
A Study in Ovarian, Non-Small Cell Lung, Prostate, Colorectal, Gastroesophageal Cancers, and Squamous Cell Carcinoma of the Head and Neck
A Phase 2 Indication Identification Study of LY2523355 in Patients With Ovarian, Non-Small Cell Lung, Prostate, Colorectal, Gastroesophageal Cancers, and Squamous Cell Carcinoma of the Head and Neck
Status: Enrolling
Updated: 10/28/2017
Clinical Research Facility
mi
from
Post Falls, ID
Click here to add this to my saved trials